GPT and fatty liver disease: No significant difference in clinical compliance was detected between the groups (RR = 0.99, 95% CI = 0.89 to 1.10, P = 0.92), and no serious adverse events were documented.<h4>Conclusion</h4>Resistance exercise notably enhances ALT levels and hepatic steatosis in patients with MASLD.